Nobel-Laureate, Professor Stefan W. Hell, to speak at Europe Biobank Week. Don’t miss #EBW21 Keynote address

Nobel-Laureate, Professor Stefan W. Hell,
to speak at Europe Biobank Week.
Don’t miss #EBW21 Keynote address

Join us for the evening Keynote address by Nobel-Laureate Stefan W. Hell

Director of Max Planck Institute for Biophysical Chemistry in Göttingen and the Max Planck Institute for Medical Research in Heidelberg, Germany.

“MINFLUX Nanoscopy and Related Matters”

Session date & time:
Tuesday, 9 November,
20:00 – 21:00 CET

Stefan W. Hell is a director at both the Max Planck Institute for Biophysical Chemistry in Göttingen and the Max Planck Institute for Medical Research in Heidelberg, Germany. He received his doctorate (1990) in physics from the University of Heidelberg.

From 1991 to 1993 Stefan W. Hell worked at the European Molecular Biology Laboratory and from 1993 to 1996 at the University of Turku, Finland. From 2003 to 2017 he also led a research group at the German Cancer Research Center (DKFZ) in Heidelberg.

He has received several awards for breaking the diffraction resolution barrier in light-focusing microscopy: most recently he shared the 2014 Kavli Prize in Nanoscience and the Nobel Prize in Chemistry.
Only 4 weeks left to benefit from #EBW21 Early Bird Rates!
Deadline – September 5
This year’s congress theme is “BIOBANKING FOR OUR FUTURE – OPPORTUNITIES UNLOCKED”.

Don’t miss your chance to be a part of the Europe Biobank Week 2021 and learn the latest in biobanking and the related fields, whether for human health or environmental needs, including biomedical and translational research. Register today!

The Europe Biobank Week 2021
Welcomes New Partners

#EBW21 welcomes new partners – Askion GmbH, Modul-Bio, AltemisLab Ltd, BC Platforms, Hamilton Storage GmbH, Fluidigm France SARL, Bluechiip Limited and GA International. We are extremely grateful for their trust and unwavering support of the Europe Biobank Week 2021!

We invite vendors, companies, or organizations from all over the world to demonstrate the latest products, services, and technologies or expertise in the field of biobanking, repository, and specimen collection, sample processing, testing or research.